EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Fabrication of Interleukin-4 Encapsulated Bioactive Microdroplets for Regulating Inflammation and Promoting Osteogenesis

Yi Zhang, Jin Cao, Minghui Jian, Zhixiao Zhou, Nadia Anwar, Lan Xiao iD, Yaping Ma, Dingmei Zhang, Jun Zhang, Xin Wang

International Journal of Nanomedicine · 2023-04 · Volume 18 · 2019-2035

DOI: 10.2147/ijn.s397359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023-04. Verfasst von Yi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hygiene Toxicology, Zunyi Medical University, Zunyi, Guizhou, 563000, People's Republic of China. Hauptthemen laut MEDLINE: Osteogenesis, Interleukin-4. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the inherent regenerative ability of bone, large bone defect regeneration remains a major clinical challenge for orthopedic surgery. Therapeutic strategies medicated by M2 phenotypic macrophages or M2 macrophage inducer have been widely used to promote tissue remodeling. In this study, ultrasound-responsive bioactive microdroplets (MDs) encapsulated with bioactive molecule interleukin-4 (IL4, hereafter designated MDs-IL4) were fabricated to regulate macrophage polarization and potentiate the osteogenic differentiation of human mesenchymal stem cells (hBMSCs). Materials and Methods: The MTT assay, live and dead staining, and phalloidin/DAPI dual staining were used to evaluate biocompatibility in vitro. H&E staining was used to evaluate biocompatibility in vivo. Inflammatory macrophages were further induced via lipopolysaccharide (LPS) stimulation to mimic the pro-inflammatory condition. The immunoregulatory role of the MDs-IL4 was tested via macrophage phenotypic marker gene expression, pro-inflammatory cytokine level, cell morphological analysis, and immunofluorescence staining, etc. The immune-osteogenic response of hBMSCs via macrophages and hBMSCs interactions was further investigated in vitro.

Results

The bioactive MDs-IL4 scaffold showed good cytocompatibility in RAW 264.7 macrophages and hBMSCs. The results confirmed that the bioactive MDs-IL4 scaffold could reduce inflammatory phenotypic macrophages, as evidenced by changing in morphological features, reduction in pro-inflammatory marker gene expression, increase of M2 phenotypic marker genes, and inhibition of pro-inflammatory cytokine secretion. Additionally, our results indicate that the bioactive MDs-IL4 could significantly enhance the osteogenic differentiation of hBMSCs via its potential immunomodulatory properties.

Conclusion

Our results demonstrate that the bioactive MDs-IL4 scaffold could be used as novel carrier system for other pro-osteogenic molecules, thus having potential applications in bone tissue regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisInterleukin-4HumansBone and BonesCytokinesImmunologic FactorsCell DifferentiationInflammation

Stichwörter der Autor:innen

IL-4bioactive microdropletsbiocompatibilityimmunoregulationmacrophagesosteogenesis

Substanzen

Interleukin-4CytokinesImmunologic Factors

Autor:innen und Institutionen

  • Department of Hygiene Toxicology, Zunyi Medical University, Zunyi, Guizhou, 563000, People's Republic of China.
  • Department of Orthopaedic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563003, People's Republic of China.
  • School of Mechanical, Medical and Process Engineering, Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, QLD, 4059, Australia.
  • Australia-China Centre for Tissue Engineering and Regenerative Medicine, Queensland University of Technology, Brisbane, QLD, 4059, Australia.

ORCID-Profile: Lan Xiao

Zitieren

APA

Zhang, Y., Cao, J., Jian, M., Zhou, Z., Anwar, N., Xiao, L., Ma, Y., Zhang, D., Zhang, J., & Wang, X. (2023). Fabrication of Interleukin-4 Encapsulated Bioactive Microdroplets for Regulating Inflammation and Promoting Osteogenesis. International Journal of Nanomedicine, Volume 18, 2019-2035. https://doi.org/10.2147/ijn.s397359

Vancouver

Zhang Y, Cao J, Jian M, Zhou Z, Anwar N, Xiao L, et al. Fabrication of Interleukin-4 Encapsulated Bioactive Microdroplets for Regulating Inflammation and Promoting Osteogenesis. International Journal of Nanomedicine. 2023;Volume 18:2019-2035. doi:10.2147/ijn.s397359

BibTeX
@article{Zhang2023,
  author = {Zhang, Yi and Cao, Jin and Jian, Minghui and Zhou, Zhixiao and Anwar, Nadia and Xiao, Lan and Ma, Yaping and Zhang, Dingmei and Zhang, Jun and Wang, Xin},
  title = {Fabrication of Interleukin-4 Encapsulated Bioactive Microdroplets for Regulating Inflammation and Promoting Osteogenesis},
  journal = {International Journal of Nanomedicine},
  year = {2023},
  volume = {Volume 18},
  pages = {2019--2035},
  doi = {10.2147/ijn.s397359}
}
Kostenlos starten →